145 related articles for article (PubMed ID: 26125810)
1. BORIS and CTCF are overexpressed in squamous intraepithelial lesions and cervical cancer.
Velázquez-Hernández N; Reyes-Romero MA; Barragán-Hernández M; Guerrero-Romero F; Rodríguez-Moran M; Aguilar-Durán M; Lazalde Medina B
Genet Mol Res; 2015 Jun; 14(2):6094-100. PubMed ID: 26125810
[TBL] [Abstract][Full Text] [Related]
2. Aberrant DNA methylation of DLX4 and SIM1 is a predictive marker for disease progression of uterine cervical low-grade squamous intraepithelial lesion.
Sakane J; Taniyama K; Miyamoto K; Saito A; Kuraoka K; Nishimura T; Sentani K; Oue N; Yasui W
Diagn Cytopathol; 2015 Jun; 43(6):462-70. PubMed ID: 25614457
[TBL] [Abstract][Full Text] [Related]
3. ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.
Park S; Lee S; Kim J; Kim G; Park KH; Kim TU; Chung D; Lee H
PLoS One; 2019; 14(4):e0214867. PubMed ID: 30973901
[TBL] [Abstract][Full Text] [Related]
4. MMP-9 expression increases according to the grade of squamous intraepithelial lesion in cervical smears.
Matheus ER; Zonta MA; Discacciati MG; Paruci P; Velame F; Cardeal LB; Barros SB; Pignatari AC; Maria-Engler SS
Diagn Cytopathol; 2014 Oct; 42(10):827-33. PubMed ID: 24578283
[TBL] [Abstract][Full Text] [Related]
5. Expression Profile of MicroRNA-203 and its ΔNp63 Target in Cervical Carcinogenesis: Prospects for Cervical Cancer Screening.
Coimbra EC; DA Conceição Gomes Leitão M; Júnior MR; DE Oliveira TH; DA Costa Silva Neto J; DE Freitas AC
Anticancer Res; 2016 Aug; 36(8):3939-46. PubMed ID: 27466497
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of Dyrk1b in the specimens and cells of cervical lesions].
Lin J; Zhang P; Pang L; Chen J; Sun W; Qi W; Lyu Y; Guan H; Gao J
Zhonghua Fu Chan Ke Za Zhi; 2016 Jan; 51(1):40-5. PubMed ID: 26899006
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation in human papillomavirus-infected cervical cells is elevated in high-grade squamous intraepithelial lesions and cancer.
Kim MK; Lee IH; Lee KH; Lee YK; So KA; Hong SR; Hwang CS; Kee MK; Rhee JE; Kang C; Hur SY; Park JS; Kim TJ
J Gynecol Oncol; 2016 Mar; 27(2):e14. PubMed ID: 26768780
[TBL] [Abstract][Full Text] [Related]
8. CADM1, MAL, and miR124 Promoter Methylation as Biomarkers of Transforming Cervical Intrapithelial Lesions.
Del Pino M; Sierra A; Marimon L; Martí Delgado C; Rodriguez-Trujillo A; Barnadas E; Saco A; Torné A; Ordi J
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067838
[TBL] [Abstract][Full Text] [Related]
9. Comparative transcriptomic profiling in HPV-associated cervical carcinogenesis: Implication of MHC class II and immunoglobulin heavy chain genes.
Balasubramaniam SD; Wong KK; Oon CE; Balakrishnan V; Kaur G
Life Sci; 2020 Sep; 256():118026. PubMed ID: 32615187
[TBL] [Abstract][Full Text] [Related]
10. Predictive Value of Cytokeratin 7 Immunohistochemistry in Cervical Low-grade Squamous Intraepithelial Lesion as a Marker for Risk of Progression to a High-grade Lesion.
Paquette C; Mills AM; Stoler MH
Am J Surg Pathol; 2016 Feb; 40(2):236-43. PubMed ID: 26551618
[TBL] [Abstract][Full Text] [Related]
11. Keratin 17 in premalignant and malignant squamous lesions of the cervix: proteomic discovery and immunohistochemical validation as a diagnostic and prognostic biomarker.
Escobar-Hoyos LF; Yang J; Zhu J; Cavallo JA; Zhai H; Burke S; Koller A; Chen EI; Shroyer KR
Mod Pathol; 2014 Apr; 27(4):621-30. PubMed ID: 24051697
[TBL] [Abstract][Full Text] [Related]
12. Distribution of human papillomavirus genotypes in Paraguayan women according to the severity of the cervical lesion.
Mendoza LP; Arbiza J; Paez M; Kasamatsu E; Castro A; Giménez G; Basiletti J; Gonzalez J; Mongelós P; Picconi MA
J Med Virol; 2011 Aug; 83(8):1351-7. PubMed ID: 21618554
[TBL] [Abstract][Full Text] [Related]
13. Association between concurrent genital bleeding and cervical cancer: a cross-sectional study.
Xavier-Júnior JC; Vale DB; Zeferino LC; Dufloth RM
Acta Obstet Gynecol Scand; 2015 Sep; 94(9):949-53. PubMed ID: 26033639
[TBL] [Abstract][Full Text] [Related]
14. The CpG island methylator phenotype increases the risk of high-grade squamous intraepithelial lesions and cervical cancer.
Loaeza-Loaeza J; Illades-Aguiar B; Del Moral-Hernández O; Castro-Coronel Y; Leyva-Vázquez MA; Dircio-Maldonado R; Ortiz-Ortiz J; Hernández-Sotelo D
Clin Epigenetics; 2022 Jan; 14(1):4. PubMed ID: 34991696
[TBL] [Abstract][Full Text] [Related]
15. High-grade squamous intraepithelial lesion (HSIL) of the cervix with bizarre cytological appearances ('pleomorphic HSIL'): a review of 19 cases.
Stewart CJR
Pathology; 2017 Aug; 49(5):465-470. PubMed ID: 28666641
[TBL] [Abstract][Full Text] [Related]
16. Immunofluorescence expression of Ki-67, p53 and cyclin inhibitors (p16ink4a, p21 and p27) in low-grade cervical lesions versus high-grade cervical lesions. Research study on cell cultures.
Stănculescu R; Ceauşu M; Ceauşu Z; Bausic V
Rom J Morphol Embryol; 2013; 54(3 Suppl):725-34. PubMed ID: 24322019
[TBL] [Abstract][Full Text] [Related]
17. The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells.
Tiffen JC; Bailey CG; Marshall AD; Metierre C; Feng Y; Wang Q; Watson SL; Holst J; Rasko JE
Int J Cancer; 2013 Oct; 133(7):1603-13. PubMed ID: 23553099
[TBL] [Abstract][Full Text] [Related]
18. Aberrantly elevated Bmi1 promotes cervical cancer tumorigenicity and tumor sphere formation via enhanced transcriptional regulation of Sox2 genes.
Xu R; Chen L; Yang WT
Oncol Rep; 2019 Aug; 42(2):688-696. PubMed ID: 31173263
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
[TBL] [Abstract][Full Text] [Related]
20. The expression of transcription factor BORIS and its association with the estrogen receptor beta (ER-β) in cervical carcinogenesis.
López-Romero R; Rodríguez-Esquivel M; Romero-Morelos P; García-Avilés JE; Serafín-Castillo A; Huerta-Padilla VM; Guerra-Araiza C; Mantilla-Morales A; Monrroy-García A; Aguilar-Urbano MA; Martínez-Castillo MA; Jiménez-Tenorio JA; Salcedo M
Int J Clin Exp Pathol; 2019; 12(9):3208-3221. PubMed ID: 31934165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
